Financial Gravity Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Financial Gravity Asset Management's PFE Position: Q1 2026 in Review
Financial Gravity Asset Management reduced its Pfizer (PFE) stake by 79% in Q1 2026, selling an estimated $18.7K and leaving 192 shares worth $5.39K. The position accounts for ﹤0.01% of the portfolio, ranked #651.
Financial Gravity Asset Management first reported a position in PFE in Q1 2018 and has held it in 17 quarters since. The position peaked at $326K in Q2 2018. 2,953 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Financial Gravity Asset Management held 192 shares of Pfizer worth $5.39K as of Q1 2026.
- Financial Gravity Asset Management sold 704 Pfizer shares in Q1 2026, an estimated $18.7K.
- Pfizer made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #651 holding.
- Financial Gravity Asset Management first reported a position in Pfizer in Q1 2018 and has held it in 17 quarters since.
- Financial Gravity Asset Management's Pfizer position peaked at $326K in Q2 2018.
- 2,953 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.